BIG
RCEL icon

Brooklyn Investment Group’s Avita Medical RCEL Stock Holding History

Brooklyn Investment Group’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,179
Closed -$48.8K – 1991
2025
Q4 		$48.8K Buy
+14,179
New +$56.6K ﹤0.01% 1492
2025
Q3 		– Sell
-119
Closed -$630 – 2206
2025
Q2 		$630 Buy
+119
New +$866 ﹤0.01% 3038

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Brooklyn Investment Group's RCEL Position: Q1 2026 in Review

Brooklyn Investment Group sold out of Avita Medical (RCEL) in Q1 2026, closing a stake of 14,179 shares — an estimated $48.8K sold.

Brooklyn Investment Group first reported a position in RCEL in Q2 2025 and held it in 2 quarters. The position peaked at $48.8K in Q4 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • Brooklyn Investment Group reported no remaining Avita Medical position as of Q1 2026 after selling out during the quarter.
  • Brooklyn Investment Group sold 14,179 Avita Medical shares in Q1 2026, an estimated $48.8K.
  • Brooklyn Investment Group first reported a position in Avita Medical in Q2 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Avita Medical position peaked at $48.8K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.